Colorectal Cancer

Latest News

Cancer detection | Image credit: lordn - stock.adobe.com
Colorectal, Pancreatic Cancer Rising in Younger Adults

April 17th 2025

There has been a sharp increase in colorectal and pancreatic cancer rates among Americans under 55 years, despite declines in older adults, according to a new study.

Hurricane Irma | Image credit: Satoshi Kina - stock.adobe.com
Disasters Likely Cause Delays in Early Colorectal Cancer Diagnosis

April 14th 2025

FDA approved. | Image Credit: Pawel - stock.adobe.com
Nivolumab Plus Ipilimumab FDA Approved for MSI-H, dMMR Colorectal Cancer

April 8th 2025

FIT outreach | Image credit: Rix Pix - stock.adobe.com
Mailed FIT Outreach Boosts CRC Screening in Medicaid Patients, Study Finds

April 8th 2025

Immune checkpoint protein | Image credit: Corona Borealis - stock.adobe.com
Data Highlights Factors Impacting Immune Checkpoint Inhibitors in mCRC

March 20th 2025

More News

What Does PD-L2 Tell Us About Advanced Colorectal Cancer?
December 30th 2020

What Does PD-L2 Tell Us About Advanced Colorectal Cancer?

Mary Caffrey
Results show the presence of PD-L2 in the tumor may be an independent predictor of survival outcomes for patients with advanced stage colon carcinoma.
obesity
December 30th 2020

Results Identify Sex-Specific Links Between Adiposity and CRC, but Much Still Unknown

Mary Caffrey
The connection between obesity and colorectal cancer is well established, but the mechanics are not understood.
NCI-Funded Study Finds Triple Therapy Packs a Punch in Metastic Colorectal Cancer
December 24th 2020

NCI-Funded Study Finds Triple Therapy Packs a Punch in Metastic Colorectal Cancer

AJMC Staff
Adding vemurafenib, known to target a mutation affecting 10% of metastatic colorectal cancers, made a big difference.
Study Probes Links Between Mutations, Metastasis in mCRC in China
December 23rd 2020

Study Probes Links Between Mutations, Metastasis in mCRC in China

Allison Inserro
Researchers sought to gain a better understanding of the relationship between genetic mutations in metastatic colon cancer (mCRC), advanced disease, and locations of primary tumors.
Guidance Describes Management of Malignant Colorectal Polyps
December 23rd 2020

Guidance Describes Management of Malignant Colorectal Polyps

Skylar Jeremias
Early detection of colon cancer is key to survival. New guidance advises endoscopists in identifying malignant colorectal polyps and recommendations for surgery.
Medicaid Expansion May Result in Earlier Colon Cancer Diagnosis, Study Says
December 13th 2020

Medicaid Expansion May Result in Earlier Colon Cancer Diagnosis, Study Says

AJMC Staff
The authors wrote that in states that expanded Medicaid health insurance coverage in 2014, there was an increase of early-stage colon cancer diagnoses compared with states that did not implement expansion.
AI Helps Determine Which Patients Benefit Most From Colorectal Cancer Treatment
December 9th 2020

AI Helps Determine Which Patients Benefit Most From Colorectal Cancer Treatment

Gianna Melillo
Researchers found the application of FOLFOXai, an artificial intelligence (AI)–based predictor of response to FOLFOX chemotherapy in metastatic colorectal cancer (mCRC), may lead to improved treatment outcomes for some patients with mCRC and other cancers.
Site Logo
November 12th 2020

Impact of Travel Distance on Quality Outcomes in Colorectal Cancer

Aaron C. Spaulding, PhD Shalmali Borkar, MBBS, MPH Osayande Osagiede, MBBS, MPH Jordan J. Cochuyt, BS Riccardo Lemini, MD Nolan Otto, BS Dorin T. Colibaseanu, MD
This study identified characteristics of patients with colorectal cancer who traveled farther for surgery and found that those who traveled tended to stay longer at the hospital.
Biomarker Use in Colorectal Cancer
December 18th 2019

Biomarker Use in Colorectal Cancer

Maggie L. Shaw
Despite a 20% drop in mortality since 2009, colorectal cancer accounted for 9.8% (881,000) of deaths worldwide in 2018 and represents 10.2% of all cancer cases worldwide. It is No. 3 on the list of most prevalent cancers worldwide—1.8 million new cases in 2018—behind only lung cancer and breast cancer.
NGS Identifies Survival, Treatment Outcomes for Patients With CRC Genetic Mutations
April 7th 2019

NGS Identifies Survival, Treatment Outcomes for Patients With CRC Genetic Mutations

Laura Joszt, MA
Genetic alternations in colorectal cancer (CRC) are linked to different survival and treatment outcomes, according to a study that used next-generation sequencing (NGS) of tumor DNA. The study was published in Journal of Clinical Oncology.
<123456

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo